Last reviewed · How we verify

NCT03848468

Comparison Study: Ligasure Versus Conventional Hemorrhoidectomy in III and IV Degree Hemorrhoids.

Completed NA Last updated 20 February 2019
What this trial tests

NA trial testing Hemorrhoidectomy in Hemorrhoidectomy in 100 participants. Completed in 30 September 2014.

Timeline
1 April 2014
Primary endpoint
30 September 2014
30 September 2014

Quick facts

Lead sponsorServices Hospital, Lahore
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment100
Start date1 April 2014
Primary completion30 September 2014
Estimated completion30 September 2014
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Services Hospital, Lahore

Who can join

Adults 19 to 80, any sex, with Hemorrhoidectomy or Hemorrhoids Third Degree. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A comparison study was performed between Ligasure and Milligan morgan hemorrhoidectomy to find out the outcome between these two techniques in 3rd and 4th degree hemorrhoids.This advance vessel sealing device is used to seal the pedicle of the vessel and does not burn the surrounding tissues , so the outcome was monitored in terms of operative time, post operative pain pain, duration of wound healing in 3 weeks and return to normal activities

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Hemorrhoidectomy

Trials testing the same drug.

Other recruiting trials for Hemorrhoidectomy

Currently open trials in the same condition.

Other Services Hospital, Lahore trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03848468.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing